XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock Based Compensation
3 Months Ended
Mar. 31, 2024
Stock Based Compensation [Abstract]  
STOCK BASED COMPENSATION

NOTE 9 - STOCK BASED COMPENSATION

 

In January 2018, the Company’s board of directors approved its 2018 Stock Incentive Plan (“2018 Plan”). The 2018 Plan provides for the grant of non-qualified stock options and incentive stock options to purchase shares of the Company’s common stock, the grant of restricted and unrestricted share awards and grant of restricted stock units. There are 131,379 shares of common stock reserved for issuance under the 2018 Plan. All of the Company’s employees and any subsidiary employees (including officers and directors who are also employees), as well as all of the Company’s nonemployee directors and other consultants, advisors and other persons who provide services to the Company will be eligible to receive incentive awards under the 2018 Plan.

 

In September 2021, the Company’s board of directors approved its 2021 Stock Incentive Plan (“2021 Plan”), which was also approved by the stockholders of the Company at the Company’s annual meeting of stockholders held on November 4, 2021. The 2021 Plan provides for the grant of non-qualified stock options and incentive stock options to purchase shares of the Company’s common stock, the grant of restricted and unrestricted share awards and grant of restricted stock units. The Company has 168,000 shares of its common stock reserved under the 2021 Plan. All of the Company’s employees and any subsidiary employees (including officers and directors who are also employees), as well as all of the Company’s nonemployee directors and other consultants, advisors and other persons who provide services to the Company will be eligible to receive incentive awards under the 2021 Plan.

 

The following table summarizes the stock-based compensation expense recorded in the Company’s results of operations during the three months ended March 31, 20204 and 2023 for stock options and warrants:

 

   For The Three Months Ended
March 31,
 
   2024   2023 
Research and development  $232,652   $243,874 
General and administrative   394,338    507,947 
   $626,990   $751,821 

 

As of March 31, 2024, there was approximately $3.2 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements that are expected to vest. This cost is expected to be recognized over a weighted-average period of 1.8 years.

 

The Company records compensation expense for awards with graded vesting using the straight-line method. The Company recognizes compensation expense over the requisite service period applicable to each individual award, which generally equals the vesting term. The Company estimates the fair value of each option award using the Black-Scholes-Merton option pricing model. Forfeitures are recognized when realized.

 

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

   Number of
Shares
   Weighted-
Average
Exercise
Prices
   Weighted-
Average
Remaining
Contractual
Term
(In Years)
   Intrinsic
Value
 
Outstanding at January 1, 2024   233,340   $74.63    7.66   $
              -
 
Granted   
-
    
-
    -    - 
Cancelled   
-
    
-
    -    - 
Outstanding at March 31, 2024   233,340   $74.63    7.41   $
-
 
Exercisable at March 31, 2024   121,387   $103.70    6.11   $
-
 

 

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those stock options that had strike prices lower than the fair value of the Company’s common stock.